|
WDR5B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.343000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.332600E-01 |
| Normal-vs-Stage2 |
9.352600E-01 |
| Normal-vs-Stage3 |
2.748800E-01 |
| Normal-vs-Stage4 |
8.626200E-01 |
| Stage1-vs-Stage2 |
8.619400E-01 |
| Stage1-vs-Stage3 |
1.211770E-01 |
| Stage1-vs-Stage4 |
8.993200E-01 |
| Stage2-vs-Stage3 |
4.034800E-01 |
| Stage2-vs-Stage4 |
8.214000E-01 |
| Stage3-vs-Stage4 |
2.002200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.771600E-01 |
| Normal-vs-AfricanAmerican |
1.431030E-01 |
| Normal-vs-Asian |
5.892200E-01 |
| Caucasian-vs-AfricanAmerican |
1.767730E-02 |
| Caucasian-vs-Asian |
4.825400E-01 |
| AfricanAmerican-vs-Asian |
8.324600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.917800E-01 |
| Normal-vs-Female |
1.729620E-01 |
| Male-vs-Female |
5.582100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.655400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.620000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.798200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.591780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.587200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.640200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.084200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.651900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.152200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.120400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.034400E-02 |
| Normal-vs-Grade 2 |
3.733800E-01 |
| Normal-vs-Grade 3 |
3.406200E-01 |
| Normal-vs-Grade 4 |
1.162600E-01 |
| Grade 1-vs-Grade 2 |
2.640800E-01 |
| Grade 1-vs-Grade 3 |
2.421600E-02 |
| Grade 1-vs-Grade 4 |
1.930410E-02 |
| Grade 2-vs-Grade 3 |
1.640230E-02 |
| Grade 2-vs-Grade 4 |
1.185850E-02 |
| Grade 3-vs-Grade 4 |
2.994800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.537800E-01 |
| Normal-vs-ccB subtype |
7.486100E-02 |
| ccA subtype-vs-ccB subtype |
1.402970E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.806800E-01 |
| Normal-vs-N1 |
4.082600E-01 |
| N0-vs-N1 |
4.419400E-01 |
|
|
